An integrated SII-PNI immune-nutritional scoring system predicts efficacy and immune-related adverse events in locally advanced gastric cancer patients undergoing neoadjuvant immunotherapy.

Front Immunol · 2026 · PMC13171329 · PMID 42148070

Europe PMC DOI

hedged sentence

0.1780

closest p · 3.6× alpha

0.1780

boldest claim

The sentences

did not reach statistical significanceP = 0.178not close (p > 0.1)

Although the pCR rate was numerically higher in the Score 0 group (11.0%) than in the Score 2 group (3.2%), the difference did not reach statistical significance (P = 0.178).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.